Previous 10 | Next 10 |
Alkermes (ALKS): Q4 Non-GAAP EPS of $0.10 beats by $0.03; GAAP EPS of -$0.27 misses by $0.08.Revenue of $280M (-32.2% Y/Y) beats by $11.31M.Press Release For further details see: Alkermes EPS beats by $0.03, beats on revenue
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2020 and Provides Financial Expectations for 2021 -- Revenues of $1.04 Billion in 2020, GAAP Loss per Share of $0.70 and Basic and Diluted Non-GAAP Earnings per Share of $0.43 -- -- Financi...
Alkermes (NASDAQ:ALKS) is scheduled to announce Q4 earnings results on Thursday, February 11th, before market open.The consensus EPS Estimate is $0.07 (-91.6% Y/Y) and the consensus Revenue Estimate is $268.69M (-34.9% Y/Y).Over the last 2 years, ALKS has beaten EPS estimates 88% of the time ...
Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results PR Newswire DUBLIN , Feb. 4, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m....
High-scoring, high short-interest stocks that can benefit from ongoing short covering by hedge funds as they reduce single stock risk. Institutional quality stocks with potential catalysts that support ongoing short covering, rather than flash-in-the-pan volatility. Ideas across a...
Results evaluating the efficacy and safety of Alkermes' (ALKS) Vivitrol (naltrexone for extended-release injectable suspension (XR-NTX)) plus oral extended-release bupropion combination treatment for adults with moderate or severe methamphetamine use disorder ((MUD)) were published ...
NIDA-Funded Study Evaluating Extended-Release Injectable Naltrexone Plus Bupropion for the Treatment of Methamphetamine Use Disorder Published in New England Journal of Medicine PR Newswire DUBLIN , Jan. 14, 2021 /PRNewswire/ -- Results from a National Insti...
Alkermes to Present at the 39th Annual J.P. Morgan Healthcare Conference PR Newswire DUBLIN , Jan. 6, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops , will provide a corporate overview a...
Alkermes (ALKS) appointed Blair C. Jackson as COO and Iain M. Brown will assume the role of CFO replacing James M. Frates who will leave the company after 20-year to pursue another opportunity.20-years industry veteran Mr. Jackson will expand his current rol...
Alkermes Announces Updates to Executive Leadership Team -- Blair C. Jackson Appointed Chief Operating Officer and Iain M. Brown Named Chief Financial Officer, Positioning Company for Continued Strong Execution of Business Strategy -- -- Newly Appointed COO and CFO Will Overs...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 10:45:03 ET Enbridge Inc (ENB) ENB is trading UP for the last 5 days, and it at trading at $36.59 with volume of 731,965 and a one day change of $0.05 (0.14%). Enbridge Inc has a 52-week low of 31.03 and a 52-week high of $38.36. The business's 50-day moving average price...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...